Idaho Falls Community Hospital is participating in another COVID-19 drug trial aimed at reducing the number of patients who need to be put in intensive care or on a ventilator. The hospital recently enrolled its first patient in the trial. The trial involves a medication called Ruxolitinib, more commonly known as Jakavi. The medication can be used in patients 12 years and olde ...
